Dr. Stephen Lieman, M.D.
What this data tells you about Dr. Lieman
Dr. Stephen Lieman is an urology physician in Plano, TX, with 19 years in practice. Based on federal Medicare data, Dr. Lieman performed 2,480 Medicare services across 1,454 unique beneficiaries.
Between the years covered by Open Payments, Dr. Lieman received a total of $6,984 from 67 pharmaceutical and/or device companies across 342 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Lieman is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Urinalysis, manual | 723 | $3 | $20 |
| Office visit, established patient (20-29 min) | 457 | $61 | $105 |
| Infectious disease DNA/RNA test | 299 | $34 | $80 |
| Office visit, established patient (30-39 min) | 255 | $84 | $150 |
| Yeast/candida DNA test | 114 | $34 | $80 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 84 | $132 | $882 |
| Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | 81 | $14 | $80 |
| New patient office visit (45-59 min) | 68 | $112 | $245 |
| Diagnostic exam of bladder and urethra using an endoscope | 65 | $176 | $425 |
| Bladder ultrasound after voiding | 61 | $7 | $100 |
| X-ray of abdomen, 1 view | 38 | $20 | $75 |
| New patient office visit (30-44 min) | 35 | $74 | $180 |
| Detection test by nucleic acid for multiple organisms, amplified probe(s) technique | 29 | $69 | $150 |
| Detection test by nucleic acid for staphylococcus aureus (bacteria), amplified probe technique | 23 | $34 | $80 |
| Detection test by nucleic acid for staphylococcus aureus, methicillin resistant (mrsa bacteria), amplified probe technique | 23 | $34 | $80 |
| Detection test by nucleic acid for strep (streptococcus, group b), amplified probe technique | 23 | $34 | $80 |
| Detection test by nucleic acid for strep (streptococcus, group a), amplified probe technique | 22 | $34 | $80 |
| Simple bladder irrigation and/or instillation | 17 | $55 | $250 |
| Detection test by nucleic acid for vancomycin resistance strep (vre), amplified probe technique | 16 | $34 | $80 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 14 | $26 | $57 |
| Biopsy of prostate gland | 11 | $85 | $450 |
| Ultrasound scan of pelvic region through rectum | 11 | $23 | $275 |
| Ultrasonic guidance for needle placement | 11 | $22 | $270 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Lieman is a clinical cardiology specialist, with moderate Medicare volume, and low-engagement industry engagement, with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Lieman experienced with urinalysis, manual?
Does Dr. Lieman receive payments from pharmaceutical companies?
How do Dr. Lieman's costs compare to other urology physicians in Plano?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology